Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 287 | 291 | PF00656 | 0.696 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.448 |
CLV_PCSK_FUR_1 | 13 | 17 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.482 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.401 |
CLV_PCSK_PC1ET2_1 | 198 | 200 | PF00082 | 0.571 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.391 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.569 |
DOC_CYCLIN_RxL_1 | 121 | 129 | PF00134 | 0.392 |
DOC_MAPK_gen_1 | 13 | 23 | PF00069 | 0.401 |
DOC_MAPK_gen_1 | 198 | 204 | PF00069 | 0.604 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.617 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.715 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.540 |
DOC_USP7_UBL2_3 | 235 | 239 | PF12436 | 0.634 |
DOC_WW_Pin1_4 | 197 | 202 | PF00397 | 0.474 |
LIG_14-3-3_CanoR_1 | 145 | 153 | PF00244 | 0.449 |
LIG_APCC_ABBA_1 | 151 | 156 | PF00400 | 0.378 |
LIG_BRCT_BRCA1_1 | 4 | 8 | PF00533 | 0.433 |
LIG_CaM_NSCaTE_8 | 19 | 26 | PF13499 | 0.520 |
LIG_CtBP_PxDLS_1 | 125 | 129 | PF00389 | 0.386 |
LIG_deltaCOP1_diTrp_1 | 96 | 104 | PF00928 | 0.399 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.412 |
LIG_FHA_2 | 109 | 115 | PF00498 | 0.414 |
LIG_FHA_2 | 264 | 270 | PF00498 | 0.608 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.393 |
LIG_LIR_Apic_2 | 11 | 17 | PF02991 | 0.429 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.406 |
LIG_LIR_Gen_1 | 117 | 126 | PF02991 | 0.460 |
LIG_LIR_Gen_1 | 148 | 159 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 117 | 122 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 148 | 154 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 203 | 209 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.545 |
LIG_PCNA_yPIPBox_3 | 24 | 35 | PF02747 | 0.431 |
LIG_Pex14_1 | 97 | 101 | PF04695 | 0.395 |
LIG_SH2_CRK | 14 | 18 | PF00017 | 0.428 |
LIG_SH2_CRK | 32 | 36 | PF00017 | 0.404 |
LIG_SH2_NCK_1 | 32 | 36 | PF00017 | 0.419 |
LIG_SH2_PTP2 | 143 | 146 | PF00017 | 0.523 |
LIG_SH2_PTP2 | 58 | 61 | PF00017 | 0.503 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.376 |
LIG_SH2_STAT3 | 130 | 133 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.379 |
LIG_SH3_3 | 119 | 125 | PF00018 | 0.400 |
LIG_SUMO_SIM_anti_2 | 200 | 206 | PF11976 | 0.605 |
LIG_SUMO_SIM_par_1 | 123 | 129 | PF11976 | 0.397 |
LIG_TRAF2_1 | 208 | 211 | PF00917 | 0.498 |
LIG_TYR_ITIM | 204 | 209 | PF00017 | 0.603 |
LIG_UBA3_1 | 20 | 24 | PF00899 | 0.414 |
LIG_WRC_WIRS_1 | 101 | 106 | PF05994 | 0.410 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.445 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.777 |
MOD_CK2_1 | 263 | 269 | PF00069 | 0.645 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.398 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.603 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.597 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.751 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.711 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.695 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.417 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.529 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.721 |
MOD_N-GLC_2 | 136 | 138 | PF02516 | 0.383 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.594 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.374 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.500 |
MOD_PIKK_1 | 2 | 8 | PF00454 | 0.668 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.461 |
MOD_PKA_2 | 144 | 150 | PF00069 | 0.455 |
MOD_PKA_2 | 214 | 220 | PF00069 | 0.536 |
MOD_PKA_2 | 244 | 250 | PF00069 | 0.665 |
MOD_Plk_1 | 126 | 132 | PF00069 | 0.377 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.438 |
MOD_Plk_1 | 192 | 198 | PF00069 | 0.426 |
MOD_Plk_1 | 86 | 92 | PF00069 | 0.539 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.426 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.425 |
MOD_ProDKin_1 | 197 | 203 | PF00069 | 0.479 |
MOD_SUMO_rev_2 | 231 | 240 | PF00179 | 0.647 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.489 |
TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.397 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.553 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.424 |
TRG_ER_diArg_1 | 187 | 189 | PF00400 | 0.469 |
TRG_Pf-PMV_PEXEL_1 | 188 | 193 | PF00026 | 0.461 |
TRG_Pf-PMV_PEXEL_1 | 75 | 79 | PF00026 | 0.549 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILX7 | Leptomonas seymouri | 77% | 100% |
A0A0S4JNA3 | Bodo saltans | 61% | 100% |
A0A1X0NU24 | Trypanosomatidae | 66% | 100% |
A0A3S7WTN6 | Leishmania donovani | 94% | 100% |
A0A422NC20 | Trypanosoma rangeli | 64% | 96% |
A4H8A8 | Leishmania braziliensis | 84% | 100% |
A4HWM8 | Leishmania infantum | 94% | 100% |
C9ZXR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
E9AQD5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5BPT4 | Trypanosoma cruzi | 64% | 99% |